401 Epizód

  1. Episode 183: Oliver Sartor - The Uromigos Legends Series

    Közzétéve: 2022. 07. 18.

  2. Episode 182: ASCO Kidney Cancer Guidelines

    Közzétéve: 2022. 07. 11.

  3. Episode 181: Relapsed Germ Cell Tumours

    Közzétéve: 2022. 06. 27.

  4. Episode 180: Enzalutamide vs active surveillance in early prostate cancer

    Közzétéve: 2022. 06. 20.

  5. Episode 179: PSMA PET for Lutetium-177 in prostate cancer

    Közzétéve: 2022. 06. 20.

  6. Episode 178: ASCO 2022: Germline variants in men of African descent with prostate cancer

    Közzétéve: 2022. 06. 07.

  7. Episode 177: ASCO 2022: ENZAMET survival update

    Közzétéve: 2022. 06. 05.

  8. Episode 176: ASCO 2022: HER-2 ADCs in Bladder Cancer

    Közzétéve: 2022. 06. 05.

  9. Episode 175: ASCO 2022: Targeting the microbiome in renal cancer

    Közzétéve: 2022. 06. 04.

  10. Episode 174: ASCO 2022: Cell free DNA as a biomarker in bladder cancer

    Közzétéve: 2022. 06. 03.

  11. Episode 173: ASCO 2022: The Atlantis Trial - maintenance cabozantinib in bladder cancer

    Közzétéve: 2022. 06. 03.

  12. Episode 172: ASCO 2022: Adjuvant everolimus in renal cancer

    Közzétéve: 2022. 06. 03.

  13. Episode 171: Antibody drug conjugates in bladder cancer: managing adverse effects

    Közzétéve: 2022. 05. 23.

  14. Episode 170: APCCC Meeting Summary

    Közzétéve: 2022. 05. 16.

  15. Episode 169: The Uromigos Paper of the Month - Novel neoadjuvant approaches in UC

    Közzétéve: 2022. 05. 09.

  16. Episode 168: Mechanisms of response to PD1 therapy in renal cancer

    Közzétéve: 2022. 05. 02.

  17. Episode 167: Highlights from EIKCS oral session

    Közzétéve: 2022. 04. 22.

  18. Episode 166: Prostate cancer debate: doublet vs triplet first line therapy

    Közzétéve: 2022. 04. 18.

  19. Episode 165: Paper of the Month - ENZAMET quality of life data

    Közzétéve: 2022. 04. 06.

  20. Episode 164: Paper of the Month - what can we learn from R3 ipilimumab/nivolumab in gastric cancer

    Közzétéve: 2022. 04. 01.

12 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Visit the podcast's native language site